Table 1.
COVID-19 Negative |
COVID-19 Positive |
p | |
---|---|---|---|
N = 1256 | N = 432 | ||
DEMOGRAPHICS | |||
Age, years (SD) | 64.8 (12.3) | 65.1 (12.7) | 0.69 |
Sex, male | 1171 (93.2) | 398 (92.1) | 0.51 |
Race | 0.14 | ||
Black | 478 (38.1) | 187 (43.3) | |
White | 96 (7.6) | 27 (6.2) | |
Other | 682 (54.3) | 218 (50.5) | |
Hispanic | 1160 (92.4) | 398 (92.1) | 0.96 |
BMI, kg/m2(SD) | 29.8 (6.9) | 30.0 (6.9) | 0.71 |
CLINICAL RISK FACTORS | |||
Smoking Status | 0.18 | ||
Current | 237 (18.9) | 62 (14.4) | |
Former | 549 (43.7) | 201 (46.5) | |
Never | 406 (32.3) | 143 (33.1) | |
Unknown | 64 (5.1) | 26 (6.0) | |
Comorbidity index, CCI (SD) | 3.6 (3.4) | 3.6 (3.3) | 0.91 |
Heart failure | 16 (1.3) | 10 (2.3) | 0.20 |
COPD | 305 (24.3) | 101 (23.4) | 0.75 |
Cirrhosis | 49 (3.9) | 18 (4.2) | 0.92 |
HIV | 16 (1.3) | 10 (2.3) | 0.20 |
Dialysis dependent renal failure | 119 (9.5) | 33 (7.6) | 0.30 |
PROCEDURAL RISK FACTORS | |||
ASA Class | 0.06 | ||
1 | 3 (0.2) | 3 (0.7) | |
2 | 195 (15.5) | 58 (13.4) | |
3 | 778 (61.9) | 260 (60.2) | |
4 | 279 (22.2) | 108 (25.0) | |
5 | 1 (0.1) | 3 (0.7) | |
General anesthesia | 737 (58.7) | 269 (62.3) | 0.21 |
Organ system of surgery | 1.00 | ||
Musculoskeletal | 263 (20.9) | 89 (20.6) | |
Urological | 250 (19.9) | 85 (19.7) | |
Gastrointestinal | 194 (15.4) | 68 (15.7) | |
Cardiovascular | 163 (13.0) | 57 (13.2) | |
Ophthalmological | 111 (8.8) | 37 (8.6) | |
Respiratory | 105 (8.4) | 35 (8.1) | |
Integumentary | 74 (5.9) | 27 (6.2) | |
Neurological | 69 (5.5) | 25 (5.8) | |
Endocrine | 9 (0.7) | 3 (0.7) | |
Gynecological | 6 (0.5) | 2 (0.5) | |
Lymphatic | 6 (0.5) | 2 (0.5) | |
Auditory | 3 (0.2) | 1 (0.2) | |
Mediastinum/Diaphragm | 3 (0.2) | 1 (0.2) | |
Urgency level | 0.92 | ||
Elective | 580 (46.2) | 196 (45.4) | |
Urgent | 544 (43.3) | 188 (43.5) | |
Emergency | 132 (10.5) | 48 (11.1) |
Data represents frequency (%) unless indicated. Averages presented as means. SD, standard deviation; BMI, body mass index; CCI, Charlson comorbidity index; COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency virus; ASA, American Society of Anesthesiologists.